Should You Buy Valeant Pharmaceuticals Intl Inc. Stock Now, Ahead Of Earnings?
February 24, 2017 at 10:50 AM EST
Valeant stock presents a very aggressive risk-reward proposition going into the earnings. Wall Street currently has an average price target $22.39 indicating 35% upside from current price.
